Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587652 · ClinicalTrials.gov registry record
Methylene Blue Chromoendoscopy in Barrett's Esophagus
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 100
- Enrollment target
NCT00587652: Completed study, sponsored by Mayo Clinic.
NCT00587652 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00587652 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This study is being done to: Determine if a temporary dye applied to the esophagus identifies areas of dysplasia (pre-cancer). Determine if certain dye patterns indicate specific grades of dysplasia. Determine if overall endoscopy costs can be reduced with this dye technique. Determine if the dye could allow fewer biopsies to be obtained in the future.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2002-12 |
| Est. Completion | 2009-12 |
What the finished NCT00587652 record still lists
NCT00587652 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00587652 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00587652 about?
NCT00587652 is a clinical study titled "Methylene Blue Chromoendoscopy in Barrett's Esophagus". This study is being done to: Determine if a temporary dye applied to the esophagus identifies areas of dysplasia (pre-cancer). Determine if certain dye patterns indicate specific grades of dysplasia. Determine if overall endoscopy costs can be reduced with this dye technique. Determine if the dye c...
What is the current status of trial NCT00587652?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2002-12. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00587652?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia